Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Academia Sinica, Allarity, Anpac Bio-Medical Science, Antengene, Athersys, Biodelivery Sciences International, Burning Rock, Celularity, China Grand Pharmaceutical and Healthcare Holdings, Dr. Reddy’s Laboratories, Enanta, Etherna Asia, Etherna Immunotherapies, GC, Glenmark, Healios, Impact, Imugene, Inmagene, Insilico Medicine Hong Kong, Ji Xing, Kissei, Kyowa Kirin, Mindrank, Mymd, Novartis, Novavax, Olix, Oyster Point, Pharmaxis, Roche, Sanotize Research and Development, Sorrento, Stemcyte, Synaffix, Takeda, Usynova, Westlake, Yuyu.